WVCTSI has announced the formation of an intensive writing group designed for investigators interested in developing National Institutes of Health (NIH) R03 applications. This five-week intensive writing group will begin in May and offers participants the opportunity to receive structured guidance and feedback on their application for the June 2018 submission deadline.
R03 research grants support a variety of projects including pilot or feasibility studies, collection of preliminary data, secondary analysis of existing data, small self-contained research projects, development of new research technology, and more.
Interested participants should visit the program webpage for additional information and complete application instructions. Applications must be submitted by 5 p.m. EST on Monday, April 16. Please email Joan Lakoski, Ph.D., WVCTSI director of proposal development, for more information
WVU Cancer Institute offering groundbreaking treatment for gastroenteropancreatic neuroendocrine tumors
The WVU Cancer Institute is participating in the implementation of a new drug therapy for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a type of tumor that can form in the pancreas or in other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix. These life-threatening tumors can spread to other organs, such as the liver.
Meshea Poore, vice president for the Division of Diversity, Equity and Inclusion at WVU, will be the special guest at a Health Sciences Town Hall during WVU’s Diversity Week celebrations.
With severe storm approaching the East Coast, WVU reminds campus community about safety and resources
The West Virginia University Police and Office of Emergency Management urges students, faculty and staff to be prepared as the state braces for the impact of Hurricane Florence, making landfall along the East Coast later this week.